Spotex
- Product NDC
- 82160-126
- 11-digit product format
- 821600126
- Labeler code
- 82160
- Product ID
- 82160-126_d3942c44-25cd-788b-e053-2a95a90aab2b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Erythromycin
- Dosage form
- GEL
- Route
- TOPICAL
- Labeler
- Pella Pharmaceuticals Co. Ltd
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2013-09-10
- Marketing end
- 0000-00-00
- Substance
- ERYTHROMYCIN
- Active strength
- 1200 mg/30g
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 82160-126-01 | Spotex | 30 g in 1 TUBE | GEL | 30 | | 130 |
| 82160-126-01 | Spotex | 1 in 1 CARTON | GEL | 1 | | 130 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 82160-126 | SPOTEX (ERYTHROMYCIN) GEL [PELLA PHARMACEUTICALS CO. LTD] | 130 | Legacy NDC, 2 package rows | 20250101_d0485ea3-984d-3193-e053-2995a90a078f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 82160-126-01 | 82160012601 | 1 TUBE in 1 CARTON (82160-126-01) > 30 g in 1 TUBE | 1 tube | 2013-09-10 | 0000-00-00 | No | No | Current |